SAHRI:Coronary Artery Disease and Platelet Dysfunction

Return to Journal of South Asian Health
CAD and Platelet Dysfunction
==Introduction==
Treatment of Acute Coronary Syndrome (ACS) involves many of the platelet modulating drugs such as Aspirin, GPIIb/IIIa inhibitors. 
Primary Prevention of Coronary Artery Disease includes Aspirin.
Secondary Prevention of CAD includes Aspirin.
Though the current models for atherosclerosis does not revolve around platelet abnormalities: the question raised here is:
1. Are there any platelet speicific pathophysiology that predispose one to have ACS.
2. Are there any interventions (other than Aspirin) that are specifically related to platelets for primary/secondary prevention.
We will first review:
1. Platelet physiology
2. Atherosclerosis physiology
==Epidemiology==
==Genetics==
==Pathophysiology==
==Clinical Presentation==
==Diagnostics==
==Treatment==
==Prognosis==
==Associated Diseases and complications==
==Bibliography==
==Further research suggestions/Discussion==